Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
207.57
USD
-5.15 (-2.42%)
Official Closing Price
Updated: 5:24 PM EST, Jan 27, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Market Briefing For Tuesday, Nov. 10
November 10, 2020
Euphoria dominated the early going, tempering a good bit later in the day, nevertheless an impressive showing and vindicated my 'not shorting' the S&P during this entire phase of action.
Tags
Technology
Pharma/Biotech
Communications
From
Blogs - TalkMarkets
Eli Lilly's Antibody Treatment For COVID-19 Gets FDA Emergency Use Authorization
November 09, 2020
The United States Food and Drug Administration has issued an emergency use authorization for Eli Lilly and Company’s (NYSE: LLY) ...
Tags
News
Coronavirus
Bamlanivimab
From
Benzinga
Lilly’s COVID-19 treatment receives emergency-use approval from FDA, stock jumps 3%
November 09, 2020
Eli Lilly & Co.'s COVID-19 antibody treatment was approved for emergency use by the Food and Drug Administration on Monday, and Lilly shares jumped more than 3% in after-hours trading.
Tags
ABC
SPX
REGN
From
MarketWatch
Price Over Earnings Overview: Eli Lilly
November 09, 2020
Right now,Eli Lilly Inc. (NYSE:LLY)share price is at $144.65, after a1.27%increase. Moreover, over the ...
Tags
News
LLY
P/E Ratio Insights
From
Benzinga
Biogen's Aducanumab Fails To Win FDA Panel Backing
November 07, 2020
Biogen Inc. failed to win the backing of the FDA panel which reviewed the BLA for its controversial Alzheimer's drug aducanumab, an antibody which targets amyloid-beta.
Tags
Pharma/Biotech
Stocks / Equities
From
Blogs - TalkMarkets
Biogen's Aducanumab Fails To Win FDA Panel Backing
November 06, 2020
Biogen Inc (NASDAQ: BIIB) failed to win the backing of the FDA panel which reviewed the BLA for its controversial Alzheimer's drug ...
Tags
LLY
General
Biotech
From
Benzinga
Stocks Reach Euphoria As Election Hedges Unwind
November 06, 2020
The stock market reached a euphoric stage on Thursday. On Wednesday, tech dominated the market. On Thursday, small caps joined the fun in what could only be described as extreme euphoria.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Investors Cheer Gridlock Potential That Could Prevent Tax, Tech, Health Care Overhauls
November 05, 2020
It’s often been said that the stock market dislikes uncertainty. So it may be a little bit of a surprise that the market rally is ...
Tags
CI
Markets
TD Ameritrade
From
Benzinga
Signs point to FDA approval for Biogen’s experimental Alzheimer’s disease treatment, though there are skeptics
November 05, 2020
Odds are increasing that Biogen’s experimental and somewhat controversial Alzheimer’s disease drug may get approved after Food and Drug Administration officials said there was enough evidence in...
Tags
Biotechnology
BIIB
Pharmaceuticals
From
MarketWatch
Incyte Earnings Miss Expectations; Tightens Outlook For Top Product
November 05, 2020
Incyte early Thursday posted earnings that fell well short of Wall Street expectations, and revenue that narrowly missed views, and INCY stock slipped early following a big jump Wednesday.
From
Investor's Business Daily
51 Biggest Movers From Yesterday
November 05, 2020
Gainers Aptevo Therapeutics Inc. (NASDAQ: APVO) shares jumped 51.2% to close at $16.98 on Wednesday. Aptevo Therapeutics, on ...
Tags
CI
PVAC
JAKK
From
Benzinga
These stocks rose the most Wednesday as investors cheered a divided government following the elections
November 04, 2020
The Nasdaq Composite Index jumped 3.9%, led by tech and health-care stocks.
Tags
NKE
DHI
PDD
From
MarketWatch
Why Eli Lilly's Stock Is Trading Higher Today
November 04, 2020
Eli Lilly (NYSE: LLY) shares are trading higher on Wednesday. The strength is potentially in sympathy with Biogen(NASDAQ: BIIB) ...
Tags
News
Benzinga
why it's moving
From
Benzinga
Notable Wednesday Option Activity: LLY, WYNN, PAYC
November 04, 2020
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Lilly (Eli) & Co (LLY), where a total volume of 29,957 contracts has been traded thus...
Tags
Stocks
From
Market News Video
40 Stocks Moving In Wednesday's Mid-Day Session
November 04, 2020
Gainers Biogen Inc. (NASDAQ: BIIB) shares jumped 40.6% to $347.39 after FDA briefing documents showed company provided evidence of ...
Tags
RGR
ACIU
CI
From
Benzinga
MTUM, LLY, AMGN, BMY: Large Outflows Detected at ETF
November 04, 2020
Symbols mentioned in this story: MTUM, LLY, AMGN, BMY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Instead of Chasing Every New Vaccine "Breakthrough," Trade the Whole Sector
November 01, 2020
As the pandemic continues to rage on, so does the race to develop a vaccine. But not every biotech company is doing well in the search for an effective vaccine or treatment.
Tags
ETFs
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Why Regeneron Is Halting Coronavirus Antibody Cocktail Study Enrollment In Patients With Severe Cases
October 30, 2020
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) faced a setback Friday in a trial evaluating its antibody cocktailREGN-COV2in ...
Tags
LLY
General
Benzinga
From
Benzinga
Why Eli Lilly is a Top 25 Dividend Giant (LLY)
October 30, 2020
Lilly (Eli) & Co (LLY) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a staggering $11854205.03B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including...
Tags
ETFs
From
ETF Channel
IBD 50 Stocks To Watch: Pharma That Treated Trump Is Building Base
October 29, 2020
Regeneron Pharmaceuticals is the IBD 50 Stocks To Watch pick for Thursday as it gets set to build a bullish base.
From
Investor's Business Daily
Gilead unexpectedly cashes in with nearly $900 million in sales of COVID-19 drug
October 29, 2020
Gilead Sciences Inc.’s prominent COVID-19 drug unexpectedly brought in $100 more million in sales than analysts had expected in the third quarter, but that doesn’t mean Wall Street’s questions about...
Tags
GILD
SPX
Pharmaceuticals
From
MarketWatch
Coronavirus update: U.S. continues to set new case records and Trump remains insistent that U.S. has ‘rounded the corner’
October 29, 2020
The U.S. death toll from the coronavirus illness COVID-19 edged closer to 228,000 on Thursday and more than 81,000 new infections were recorded in a single day, pushing the seven-day tally to record...
Tags
TPX
DD
REGN
From
MarketWatch
Regeneron Posts Positive Data For Covid-19 Treatment; Lung Cancer Drug Advances
October 29, 2020
Regeneron Pharmaceuticals late Wednesday posted positive clinical trials data on its Covid-19 treatment and Thursday said a lung cancer drug received FDA priority review. Regeneron stock rose.
From
Investor's Business Daily
Regeneron Says COVID-19 Antibody Cocktail Reduced Viral Load, Need For Medical Care In Late-Stage Trial
October 28, 2020
Regeneron Pharmaceuticals, Inc (NASDAQ: REGN) said Wednesday data from late-stage clinical trials is indicative that its antibody ...
Tags
Covid/19
Market News
News
From
Benzinga
Amgen Earnings, Sales Top Wall Street Views; Hikes Earnings Guidance
October 28, 2020
Amgen posted third-quarter earnings and sales that beat Wall Street views and hiked it earnings outlook, and Amgen stock rose after hours after hitting four-month lows in the regular session.
From
Investor's Business Daily
IWF, AMGN, LOW, LLY: ETF Outflow Alert
October 28, 2020
Symbols mentioned in this story: IWF, AMGN, LOW, LLY Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Eli Lilly Inks Covid-19 Treatment Supply Deal With U.S. Despite Drug's Recent Failure
October 28, 2020
Eli Lilly inked a deal to sell up to 650,000 vials of its Covid-19 treatment candidate to the U.S., though the drug has failed a test in treating hospitalized patients. LLY stock slipped.
From
Investor's Business Daily
The Daily Biotech Pulse: Sanofi-GlaxoSmithKline To Supply 200M Doses To COVID-19 Vaccine Alliance, Gilead Earnings, Biodesix Debuts
October 28, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
UTHR
Trading Ideas
GNMK
From
Benzinga
52 Biggest Movers From Yesterday
October 28, 2020
Gainers Scholar Rock Holding Corporation (NASDAQ: SRRK) shares jumped 118.8% to close at $30.02 on Tuesday after the company ...
Tags
Movers From Yesterday
KNL
AMKR
From
Benzinga
After The Drop, Wait And See
October 27, 2020
After the huge global selloff yesterday, markets around the world are in wait-and-see mode overall, but reacting to real news when it hits.
Tags
Financial
Healthcare
Energy
From
Blogs - TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.